Senate, CA urged to release 2 detained Pharmally execs | Inquirer

Senate, CA urged to release 2 detained Pharmally execs

By: - Reporter /
/ 07:53 PM April 23, 2022

MANILA, Philippines — The legal counsel of two detained Pharmally Pharmaceutical Corporation officials have called on the Senate and Court of Appeals for the release of his clients.

Lawyer Ferdinand Topacio, in a Twitter post on Friday, said his clients Pharmally director Linconn Ong and corporate secretary and treasurer Mohit Dargani are being “unfairly imprisoned.”

Topacio also pointed out that the two “has been languishing in jail with no charges, much less a crime committed.”

Article continues after this advertisement

“Justice delayed is truly justice denied, not only for the litigants, but for their loved ones who also suffer, especially when the head of the family is unfairly imprisoned,” the lawyer continued.

FEATURED STORIES

It can also be recalled that Ong and Dargani have begged to be released and be held under house arrest instead.

READ: 2 detained Pharmally execs beg to be released, ask for house arrest

Article continues after this advertisement

Ong and Dargani have been detained at the Pasay City Jail since November last year after they failed to produce Pharmally’s financial documents in connection with the committee’s probe on the government’s alleged anomalous deal with the company.

je
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the and acknowledge that I have read the .

MOST READ
www
business
www
globalnation
sports
TAGS: Linconn Ong, Mohit Dargani, Pharmally, Senate

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the and acknowledge that I have read the .

© Copyright 1997-2024 | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies.